Eli Lilly has announced plans to expand its domestic medicine production in the US by establishing four new pharmaceutical manufacturing sites. The move increases the company's total US capital ...

Elsewhere in the state, Eli Lilly has invested heavily in a manufacturing campus in Concord. The company last year opened a $2 billion manufacturing campus that spans more than 1 million square ...

Eli Lilly said Wednesday it will invest $27 billion to build four new manufacturing plants in the United States as the pharmaceutical giant grapples with the threat of drug import duties from the ...

In addition, due for completion in 2027 is the company’s $1.7 billion plant in Concord, North Carolina. All told, Eli Lilly has tallied up about $23 billion in U.S. manufacturing commitments in ...

Eli Lilly (LLY) announces it will invest $27 billion in four new manufacturing sites in the US. Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination to break down the news.

Eli Lilly plans to invest $27 billion in four new pharmaceutical manufacturing facilities in the U.S., expanding its domestic production of medications across multiple therapeutic areas.

They want to avoid the negative impacts of tariffs on their business. One firm doing just this is Eli Lilly and Company (NYSE: LLY). The firm announced it will be investing $27 billion in the U.S ...